Replies to post #196424 on Biotech Values

[DewDiligence]

ELGX -27% on manufacturing issue that apparently warrants two separate CCs:

http://finance.yahoo.com/news/endologix-announces-temporary-hold-afx-123000898.html

Endologix, Inc…today announced a temporary hold on shipments of its AFX Endovascular AAA System to complete an investigation of a manufacturing issue with some sizes of the device. The company expects the temporary hold to be lifted for some sizes in the near future.

The Company will host a conference call today, December 27, 2016 at 9:00 am ET to provide a brief update on the AFX manufacturing issue, with an additional update conference call planned by December 30, 2016 (details to follow in a separate press release).

Either management is exceptionally shareholder-friendly, or they get paid a bonus each time they speak on a CC.